These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 5897136)

  • 1. [Increase in the serum oxytocinase activity in the blood following 17-alpha-hydroxyprogesterone capronate or allylestrenol administration].
    Semm K
    Arch Gynakol; 1965; 202():459-61. PubMed ID: 5897136
    [No Abstract]   [Full Text] [Related]  

  • 2. [Endocrinologic action spectrum of 19-nor-17-alpha-hydroxyprogesterone capronate (Gestonorone capronate)].
    Neumann F; Kramer M; Raspé G
    Arzneimittelforschung; 1968 Oct; 18(10):1289-97. PubMed ID: 5755710
    [No Abstract]   [Full Text] [Related]  

  • 3. [Study of the clinical effectiveness of 17-hydroxyprogesterone capronate (Hormofort)].
    Sas M; Farkas M; Szegvári M
    Orv Hetil; 1967 Jun; 108(23):1066-9. PubMed ID: 5624867
    [No Abstract]   [Full Text] [Related]  

  • 4. [On the effect of norhydroxyprogesterone capronate on adenocarcinoma of the corpus uteri in tissue culture].
    Heckmann U
    Dtsch Med Wochenschr; 1965 Dec; 90(52):2328-30. PubMed ID: 5851381
    [No Abstract]   [Full Text] [Related]  

  • 5. [The comparative effects of progesterone and 17-hydroxyprogesterone capronate on the incroporation of H3-thymidine and H3-uridine into the nuclei of Hela cells].
    Blokhina EM; Zelenina IA
    Farmakol Toksikol; 1973; 36(5):592-5. PubMed ID: 4788070
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of 17-alpha-hydroxy-progesterone capronate on the motility of the human uterus in puerperium following abortion].
    Data PG; Morra C; Lanza A; Scaramuzza P
    Boll Soc Ital Biol Sper; 1973 Mar; 49(9):471-6. PubMed ID: 4787512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of 17alpha-hydroxyprogesterone caproate and of 6alpha-methyl-17alpha-hydroxyprogesterone acetate on hexosekinase, phosphofructose kinase and pyruvate kinase of the human myometrium].
    Lanza A
    Minerva Ginecol; 1969 Nov; 21(21):1455-61. PubMed ID: 4252189
    [No Abstract]   [Full Text] [Related]  

  • 8. [Action of estrogens on the endometrium and mammae of castrated monkeys].
    Martínez JM; Sánchez-Garrido F; Aguilar A; Sánchez-Alonso F; Nogales F
    Acta Ginecol (Madr); 1975 Feb; 26(3):141-64. PubMed ID: 1130160
    [No Abstract]   [Full Text] [Related]  

  • 9. [The study of the effectiveness of 17-alpha-hydroxyprogesterone capronate in the treatment of threatened abortion].
    Kubinyi J; Pilishegyi J
    Orv Hetil; 1969 Mar; 110(12):654-5. PubMed ID: 4889626
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical application of 17 alpha-hydroxyprogesterone 17-n-caproate.
    GOLD JJ; COHEN MR
    Ann N Y Acad Sci; 1958 Jul; 71(5):691-703. PubMed ID: 13583824
    [No Abstract]   [Full Text] [Related]  

  • 11. [Serum oxytocinase in prolonged pregnancy and pre-eclampsia].
    Lambrinopoulos T; Ichaliotis S; Cambolis N
    Geburtshilfe Frauenheilkd; 1966 May; 26(5):534-6. PubMed ID: 5935239
    [No Abstract]   [Full Text] [Related]  

  • 12. [INCREASE IN MATERNAL SERUM OXYTOCINASE LEVEL CAUSED BY ADMINISTRATION OF A GESTAGEN IN THREATENED ABORTION].
    SEMM K; BERNHARD J
    Geburtshilfe Frauenheilkd; 1964 Nov; 24():980-5. PubMed ID: 14333236
    [No Abstract]   [Full Text] [Related]  

  • 13. [To the question of a masculinization of the fetus by hydroxy-nor-progesterone-capronate].
    Mey R
    Arzneimittelforschung; 1967 Apr; 17(4):439-40. PubMed ID: 5632437
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of human diabetic pregnancies with estradiol valerate and 17 alpha-hydroxyprogesterone 17-n-caproate.
    GILLESPIE L; SEXTON LI; WHITE P
    Ann N Y Acad Sci; 1958 Jul; 71(5):794-9. PubMed ID: 13583834
    [No Abstract]   [Full Text] [Related]  

  • 15. Attempts to induce and maintain pregnancy in prepuberal mice following treatment with 17 alpha-hydroxyprogesterone 17-n-caproate.
    SMITHBERG M
    Ann N Y Acad Sci; 1958 Jul; 71(5):555-9. PubMed ID: 13583811
    [No Abstract]   [Full Text] [Related]  

  • 16. The use of 17-alpha-hydroxyprogesterone caproate to maintain pregnancy.
    MEYERHOFF KH; BROWN WH; CIOFFI LA
    Curr Ther Res Clin Exp; 1962 Oct; 4():499-505. PubMed ID: 13935332
    [No Abstract]   [Full Text] [Related]  

  • 17. Double-blind study of effect of 17-hydroxyprogesterone caproate on abortion rate.
    SHEARMAN RP; GARRETT WJ
    Br Med J; 1963 Feb; 1(5326):292-5. PubMed ID: 13977012
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical use of 17 alpha-hydroxyprogesterone 17-n-caproate in habitual abortion.
    REIFENSTEIN EC
    Ann N Y Acad Sci; 1958 Jul; 71(5):762-86. PubMed ID: 13583832
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical use of 17 alpha-hydroxyprogesterone 17-n-caproate in the prevention of premature labor, and its effect upon fetal salvage.
    EICHNER E
    Ann N Y Acad Sci; 1958 Jul; 71(5):787-93. PubMed ID: 13583833
    [No Abstract]   [Full Text] [Related]  

  • 20. Metabolism of 17 alpha-hydroxyprogesterone-4-C14-17 alpha-caproate by homogenates of rat liver and human placenta.
    WIENER M; LUPU CI; PLOTZ EJ
    Acta Endocrinol (Copenh); 1961 Apr; 36():511-9. PubMed ID: 13785108
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.